Bird&Be has raised $13 million to scale its fertility products nationwide. The round was led by BDC Thrive and BFG Partners with participation from BAM Ventures, Founder Collective, Rejuvenation Ventures, and HSR Ventures.
With an estimated one in six couples experiencing infertility and the supplement market becoming more crowded, Samantha Diamond and Breanna Hughes launched Bird&Be in 2021 to offer a trusted resource for people trying to conceive.
Since then, the company has grown into an eight-figure brand with nearly 100% YoY growth. Expanding its product lineup, Bird&Be now offers prenatals, at-home testing kits, and male fertility supplements.
“We intentionally created a brand that would bring men into the fertility narrative as well, giving them the supplements and tools to care for their own reproductive health and grow their families,” Diamond said.
The latest round of funding will support new product innovation and continued retail expansion – Bird&Be recently entered nearly 1,000 Ulta Beauty doors and partnered with Mandell’s Clinical Pharmacy to bring products to patients undergoing treatment nationwide.
“We’ve been able to support hundreds of thousands of people in their fertility journeys over the past few years and the new funding helps us make trusted products even more accessible when and where people need care most,” Diamond said.
